TEPI PATCH
Live / Registered — Cancelled — Section 71 (as of 09 Feb 2024)
What this means for you
Registered since 25 Jul 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79191634
- Registration number
- 5248166
- Mark type
- Stylized text
- Filed
- 08 Jul 2016
- Published for opposition
- 09 May 2017
- Registered
- 25 Jul 2017
- Attorney of record
- Charles G. Zug
Goods and services
- Class 005 — Pharmaceuticals: Transdermal drug delivery agents, namely, transdermal drug delivery devices featuring active pharmaceutical ingredients for the treatment of a wide variety of conditions, NSAIDS for pain relief, smoking cessation preparations, vitamins for increasing energy, caffeine and other stimulants, lidocaine for controlling pain and heart function, hormones to supplement a lack of naturally occurring hormones or to substitute other hormones for naturally occurring hormones, opioids and other pain relievers, pain management preparations
- Class 010 — Medical apparatus: Transdermal drug delivery devices sold without medication
Owner
- Medherant Ltd, GB
- Medherant Ltd, GB
- Medherant Ltd, GB
Prosecution history
- 10 Sept 2026 — INTERNATIONAL REGISTRATION RENEWED
- 10 Oct 2024 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 09 Feb 2024 — CANCELLED SECTION 71
- 25 Jul 2022 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 02 Oct 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 24 Nov 2017 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 02 Nov 2017 — FINAL DISPOSITION NOTICE SENT TO IB
- 01 Nov 2017 — FINAL DISPOSITION PROCESSED
- 25 Oct 2017 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 25 Jul 2017 — REGISTERED-PRINCIPAL REGISTER
- 09 May 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 May 2017 — PUBLISHED FOR OPPOSITION
- 05 May 2017 — NOTIFICATION PROCESSED BY IB
- 19 Apr 2017 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 19 Apr 2017 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB